» Articles » PMID: 32938237

Effect of Vitamin E on Low Density Lipoprotein Oxidation at Lysosomal PH

Overview
Journal Free Radic Res
Publisher Informa Healthcare
Specialty Biochemistry
Date 2020 Sep 17
PMID 32938237
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Many cholesterol-laden foam cells in atherosclerotic lesions are macrophages and much of their cholesterol is present in their lysosomes and derived from low density lipoprotein (LDL). LDL oxidation has been proposed to be involved in the pathogenesis of atherosclerosis. We have shown previously that LDL can be oxidised in the lysosomes of macrophages. α-Tocopherol has been shown to inhibit LDL oxidation , but did not protect against cardiovascular disease in large clinical trials. We have therefore investigated the effect of α-tocopherol on LDL oxidation at lysosomal pH (about pH 4.5). LDL was enriched with α-tocopherol by incubating human plasma with α-tocopherol followed by LDL isolation by ultracentrifugation. The α-tocopherol content of LDL was increased from 14.4 ± 0.2 to 24.3 ± 0.3 nmol/mg protein. LDL oxidation was assessed by measuring the formation of conjugated dienes at 234 nm and oxidised lipids (cholesteryl linoleate hydroperoxide and 7-ketocholesterol) by HPLC. As expected, LDL enriched with α-tocopherol was oxidised more slowly than control LDL by Cu at pH 7.4, but was not protected against oxidation by Cu or Fe or a low concentration of Fe at pH 4.5 (it was sometimes oxidised faster by α-tocopherol with Cu or Fe at pH 4.5). α-Tocopherol-enriched LDL reduced Cu and Fe into the more pro-oxidant Cu and Fe faster than did control LDL at pH 4.5. These findings might help to explain why the large clinical trials of α-tocopherol did not protect against cardiovascular disease.

Citing Articles

Synthesis and evaluation of antioxidant activity of some novel hydroxypyridinone derivatives: a DFT approach for explanation of their radical scavenging activity.

Fassihi A, Hasanzadeh F, Movahedian Attar A, Saghaie L, Mohammadpour M Res Pharm Sci. 2021; 15(6):515-528.

PMID: 33828595 PMC: 8020857. DOI: 10.4103/1735-5362.301336.